ORASURE TECHNOLOGIES, INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
ORASURE TECHNOLOGIES, INC (OSUR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$2.80 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2021-03-01
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2020 was -$2.80K, a 275.00% decline from fiscal 2019.
- ORASURE TECHNOLOGIES, INC effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2019 was $1.60K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2020-12-31 | -$2.80K 10-K · filed 2021-03-01 |
| 2019-12-31 | $1.60K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |